# Subphenotype- and Complication-guided Adjunctive Fosfomycin Therapy for Staphylococcus Aureus Bacteraemia

> **NCT07155590** · — · ACTIVE_NOT_RECRUITING · sponsor: **Hospital Universitari de Bellvitge** · enrollment: 369 (actual)

## Conditions studied

- Staphylococcal Aureus Infection
- Staphylococcus Aureus Bacteraemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07155590
- **Lead sponsor:** Hospital Universitari de Bellvitge
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-21
- **Primary completion:** 2025-08-04
- **Final completion:** 2025-09-15
- **Target enrollment:** 369 (ACTUAL)
- **Last updated:** 2025-09-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07155590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07155590, "Subphenotype- and Complication-guided Adjunctive Fosfomycin Therapy for Staphylococcus Aureus Bacteraemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07155590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*